Shanxi Zhendong Pharmaceutical: Announcement on the Reply to the Inquiry Letter of Shenzhen Stock Exchange Annual Report
Shanxi Zhendong Pharmaceutical: Reply from Zhongshen Hua Certified Public Accountants (Special General Partnership) on the relevant issues inquired in the annual report inquiry letter of Shanxi Zhendong Pharmaceutical Co., Ltd.
Shanxi Zhendong Pharmaceutical: May 20, 2024 Investor Relations Activity Schedule
Shanxi Zhendong Pharmaceutical: Announcement on the repurchase of shares for cancellation and reduction of registered capital and notification to creditors
Shanxi Zhendong Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Shanxi Zhendong Pharmaceutical: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors
Shanxi Zhendong Pharmaceutical: Legal Opinion of Beijing Dacheng Law Firm on the 2023 Annual General Meeting of Shareholders of Shanxi Zhendong Pharmaceutical Co., Ltd.
Shanxi Zhendong Pharmaceutical: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Shanxi Zhendong Pharmaceutical: Announcement on the release and pledge of shareholders' shares
Shanxi Zhendong Pharmaceutical: Notice on changing the venue for the 2023 Annual General Meeting of Shareholders
Shanxi Zhendong Pharmaceutical: Announcement on attending the 2024 Online Investor Group Reception Day and Annual Report Performance Briefing for Listed Companies in the Shanxi Region
Shanxi Zhendong Pharmaceutical: Articles of Association (May 2024)
Shanxi Zhendong Pharmaceutical: Notice on reducing registered capital and amending the Articles of Association
Shanxi Zhendong Pharmaceutical: Announcement on the progress of the repurchase of the company's shares, the results of the repurchase and changes in shares
Shanxi Zhendong Pharmaceutical: Announcement of Resolutions of the 13th Meeting of the Fifth Board of Supervisors
Shanxi Zhendong Pharmaceutical: Announcement of Resolutions of the 17th Meeting of the Fifth Board of Directors
Shanxi Zhendong Pharmaceutical: Announcement on Additional Provisional Proposals for the 2023 Annual General Meeting of Shareholders and Supplementary Notice to the Shareholders' Meeting
Shanxi Zhendong Pharmaceutical: Notice on cancellation of share repurchases
Shanxi Zhendong Pharmaceutical: Announcement on the release and pledge of shareholders' shares
Shanxi Zhendong Pharmaceutical: Announcement on the repurchase ratio of the company's shares reaching 2% and the progress of the repurchase
No Data